Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin

American Journal of Cardiology

Volumn 79, Issue 12, 1997, Pages 1673-1676

  Takagi, Tsutomu ^a   Yoshida, Kiyoshi ^a   Akasaka, Takashi ^a   Hozumi, Takeshi ^a   Morioka, Shigefumi ^a   Yoshikawa, Junichi ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRAVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIET THERAPY; DRUG EFFICACY; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVASCULAR ULTRASOUND; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANTICHOLESTEREMIC AGENTS; CONSTRICTION, PATHOLOGIC; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PRAVASTATIN; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0030853946     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00221-X     Document Type: Article

References (16)

1. Potkin BN, Bartorelli AL, Gessert JM, Neville RF, Almagor Y, Roberts WC, Leon MB. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation. 81:1990;1575-1585.
2. Gussenhoven EJ, Essed CE, Lancee CT, Mastik F, Frietman P, van Egmond FC, Reiber J, Bosch H, van Urk H, Roelandt J, Bom N. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. J Am Coll Cardiol. 14:1989;947-952.
3. Hausmann D, Lundkvist AJS, Friedrich GJ, Mullen WL, Fitzgerald PJ, Yock PG. Intracoronary ultrasound imaging: intraobserver and interobserver variability of morphometric measurements. Am Heart J. 128:1994;674-680.
4. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Athelosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol. 25:1995;1479-1485.
5. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ, Chou TM, Ports TA, Kane JP, Malloy MJ, Yock PG. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol. 27:1996;1562-1570.
6. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
7. Nishimura RA, Edwards WD, Warnes CA, Reeder GS, Holmes DR Jr, Tajik AJ, Yock PG. Intravascular ultrasound imagings: in vitro validation and pathologic correlation. J Am Coll Cardiol. 16:1990;145-154.
8. Mallery JA, Tobis JM, Griffith J, Gessert J, McRae M, Moussabeck O, Bessen M, Moriuchi M, Henry WL. Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J. 119:1990;1392-1400.
9. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. Am J Cardiol. 72:1993;1031-1037.
10. Byington RP, Jukema JW, Salonen JT, Pitt B, Brunschke AV, Hoen H, Furberg CD, Mancini GBJ. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation. 92:1995;2419-2425.
11. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
12. Jukema JW, Bruschke AV, van Boven AJ, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, van Rappard FM, Lie KL. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderate elevated serum cholesterol levels: the regression growth evaluation statin study (REGRESS). Circulation. 91:1995;2528-2540.
13. Katoh K, Mizuno K, Nimura S, Fukuchi S. Efficacy, safety, and tolerability of pravastatin for the long-term treatment of patients with diverse types of hyperlipidemia: a multicenter prospective study. Curr Ther Res. 54:1993;500-507.
14. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes I. N Engl J Med. 326:1992;242-250.
15. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes II. N Engl J Med. 326:1992;310-318.
16. Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am J Med. 97:1994;242-249.